Here, we described a co-delivery of multiple bispecific biologics in a heterogeneous in vivo tumor model wherein NSG mice are orthotopically challenged with a mixture of EGFRvIII-expressing tumor cells (U87vIII) and HER2-expressing tumor cells (U251). Here, ERBB2 is linked to neoplasm.